This inventor holds 7 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: Novartis Ag, Novartis Pharma Gmbh. Active years: 2012-2015.
Company Filing History:
7 out of 3,974 
2 out of 8 Years Active: 2012-2015
Title: A Spotlight on Jörg Brozio: Innovator from Basel
Introduction
Jörg Brozio is a notable inventor based in Basel, Switzerland, known for his contributions to the field of pharmaceuticals and innovative chemical compounds. With a total of seven patents to his name, Brozio has made significant strides in advancing drug formulation and development.
Latest Patents
Among his latest patents are the "Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide," which highlights the development of specialized salts. Additionally, he has patented "Crystalline forms of 4-methyl-N-3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide," which focuses on various crystalline forms of this compound and its preparation through distinct processes.
Career Highlights
Jörg Brozio has held positions at esteemed organizations such as Novartis AG and Novartis Pharma GmbH. His experience in these leading pharmaceutical companies has played a crucial role in shaping his expertise and innovations in drug development.
Collaborations
Throughout his career, Brozio has collaborated with esteemed colleagues, including Paul William Manley and Wen-Chung Shieh. These partnerships have enriched his inventions and expanded the scope of his research, contributing to the significant advancements in their field.
Conclusion
As a talented inventor, Jörg Brozio continues to drive innovation in pharmaceuticals with his patents and collaborative efforts. His work is a testament to the importance of creativity and research in the ongoing development of effective medical treatments.